Skip to main content

Charles J. Dockendorff

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Charles J. Dockendorff

Charles J. Dockendorff was last confirmed as Board Member at Haemonetics Corp (HAE) in a filing dated June 6, 2025. The company reported in an 8-K filed April 7, 2026 that Charles J. Dockendorff resigned as director, effective April 7, 2026.

“Pursuant to the Merger Agreement, at the Effective Time, the following persons, who were directors of the Company immediately prior to the completion of the Merger, voluntarily resigned from the board of directors of the Company (the "Board") and from any and all committees of the Board on which they served: Stephen P. MacMillan, Charles J. Dockendorff, Ludwig N. Hantson, Martin Madaus, Wayde McMillan, Nanaz Mohtashami, Christiana Stamoulis, Stacey D. Stewart and Amy M. Wendell.”
Company Form 8-K, filed April 7, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Haemonetics Corp (HAE)

    Board Member

    Proxy statement

    2014-01-01–2025-06-06

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.